Introduction {#section1-2324709620910645}
============

*Actinomyces* species are gram-positive, facultative anaerobic bacilli. They can be part of oral cavity, gastrointestinal tract, and vaginal flora. Infection caused by *Actinomyces* species is usually indolent and is typically limited to cervicofacial, thoracic, and abdominopelvic regions.^[@bibr1-2324709620910645]^ Actinomycotic endocarditis is extremely rare. In this article, we describe the first case of infective endocarditis caused by *Actinomyces oris*.

Case Presentation {#section2-2324709620910645}
=================

A previously healthy 14-year-old boy from the western part of Thailand presented with a 2-week history of dyspnea on exertion. He had no fever or other constitutional symptoms suggestive of infection. He denied history of cardiac diseases, recent dental procedures, or intravenous drug use. Physical examination at the referring hospital was notable for a systolic ejection murmur grade 3/6 at the left upper sternal border. The lungs were clear, and the liver was 3 cm below the right costal margin. Laboratory evaluation revealed a white blood cell count of 16 200/µL with 76% neutrophils, hemoglobin of 13 g/dL, platelet count of 464 000/µL, an erythrocyte sedimentation rate of 7 mm/h, and an anti-streptolysin O titer \>400 IU. A chest X-ray revealed evidence of congestive heart failure. In addition to diuretics and inotropic drugs, benzathine penicillin and oral prednisolone were given as presumed acute rheumatic fever. He later developed a high-grade fever without any foci of infection. Meropenem was started empirically without obtaining a blood culture. He did not respond to initial therapy and was referred to our hospital.

Physical examination at our hospital revealed an afebrile child with stable vital signs but had gross dental caries. Subcutaneous nodules, Osler's nodes, Janeway lesions, and splinter hemorrhages were absent. Cardiac examination showed both left and right ventricular heave, normal S1, loud P2, a to-and-fro murmur grade 3/6 at left upper sternal border, and a pansystolic murmur grade 3/6 at apex. Neurological and fundoscopic examinations were unremarkable. Laboratory findings included a white blood cell count of 6700/µL with 83% neutrophils, a hemoglobin level of 12 g/dL, platelet count of 242 000/µL, and an erythrocyte sedimentation rate of 6 mm/h. Urinalysis revealed 0 to 1 white blood cell/high-power field and over 20 red blood cells/high-power field. Chest X-ray showed cardiomegaly with pulmonary congestion. Transthoracic echocardiogram revealed biventricular hypertrophy with an ejection fraction of 49% with evidence of severe aortic valve (AV) regurgitation with a suspected perforation of both the right coronary cusp 5.2 × 5.6 mm and noncoronary cusp 5 × 8 mm, severe mitral valve (MV) regurgitation with an abnormal MV leaflet. No vegetations were seen. These findings suggested infective endocarditis according to the modified Duke criteria.^[@bibr2-2324709620910645],[@bibr3-2324709620910645]^ Four sets of blood cultures were obtained, and he was empirically treated with ampicillin/sulbactam (3 g every 6 hours) and gentamicin (120 mg every 8 hours). No organisms were isolated after 5 days of incubation. He subsequently underwent surgical AV repair as indicated by worsening cardiac function. Operative findings revealed severely damaged MV and AV due to restriction and thickened cusps and a circular thinning lesion on the right coronary cusp. However, no vegetation or perforation was noted. The MV was repaired, and the AV was replaced ([Figure 1](#fig1-2324709620910645){ref-type="fig"}).

![Gross pathology of mitral valve. Circular thinning lesion on the right cusp without perforation is shown.](10.1177_2324709620910645-fig1){#fig1-2324709620910645}

Mitral valve and AV tissues were obtained for aerobic culture and 16s rRNA sequencing, which initially were unable to culture or identify an organism. The histopathologic examination of both valves revealed white myxomatous degeneration and fibrosis without vegetation or perforation, compatible with post-inflammatory valve disease. The terminal subculture in a thioglycolate broth grew gram-positive, small branching bacilli after 120 hours of incubation ([Figure 2](#fig2-2324709620910645){ref-type="fig"}).

![Gram stain of the organism grown from mitral valve tissue culture in thioglycolate broth. Gram stain showed gram-positive bacilli with small branching.](10.1177_2324709620910645-fig2){#fig2-2324709620910645}

The biochemical tests and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) were compatible with *A oris*, with the susceptibility test as shown in [Table 1](#table1-2324709620910645){ref-type="table"}. The patient was diagnosed with *A oris* endocarditis with suspected underlying rheumatic heart disease. Antibiotics were switched to intravenous ampicillin (12 g/day) for 6 weeks. The follow-up echocardiography showed an ejection fraction of 45% with trivial AV regurgitation and mild MV regurgitation. Ampicillin was switched to oral amoxicillin 2 g twice daily for a planned 12-month total course. At the follow-up visit 6 months later, he remained well and improved from functional class IV to II.

###### 

Susceptibility Testing of *Actinomyces oris*.

![](10.1177_2324709620910645-table1)

  Drugs                           MIC (µg/mL)   Interpretation
  ------------------------------- ------------- ----------------
  Penicillin                      0.12          S
  Gentamicin                      ≤2            S
  Rifampicin                      ≤0.5          S
  Vancomycin                      1             S
  Clindamycin                     0.5           S
  Erythromycin                    ≤0.25         S
  Tetracycline                    ≤2            S
  Linezolid                       1             S
  Trimethoprim-sulfamethoxazole   \>4           R
  Daptomycin                      \>4           R
  Ciprofloxacin                   4             R

Abbreviations: MIC, minimal inhibitory concentration; S, susceptible; R, resistant.

Literature Review {#section3-2324709620910645}
=================

Previously reported cases of endocarditis caused by *Actinomyces spp* were searched by using the keywords "actinomyces spp" OR "actinomyces" OR "actinomycotic" AND "infective endocarditis" OR "endocarditis" in PubMed database.

Discussion {#section4-2324709620910645}
==========

*Actinomyces* species is a gram-positive, filamentous, facultative anaerobic bacilli. Infective endocarditis caused by *Actinomyces* species is rare with only 30 reported cases since 1939. To date, 14 species of *Actinomyces* have been implicated in endocarditis: *Actinomyces bovis, Actinomyces graminis, Actinomyces septicus, Actinomyces muris, Actinomyces israelii, Actinomyces viscosus, Actinomyces meyeri, Actinomyces pyogenes, Actinomyces funkei, Actinomyces odontolyticus, Actinomyces neuii, Actinomyces georgiae, Actinomyces turicensis*, and *Actinomyces naeslundii*. To the best of the authors' knowledge, this is the first reported case of *A oris* as a causative organism of infective endocarditis.

*Actinomyces oris* is one of the predominant organisms colonizing the oral cavity and plays a role in dental plaque formation. This species previously belonged to the *A naeslundii/A viscosus* group. However, the multilocus sequence analysis based on sequence comparisons for partial gene sequences has further speciated and proposed *A oris* as a new species of *Actinomyces*. Furthermore, a phylogenetic tree based on 16s rRNA gene sequence of the genus *Actinomyces* has clearly showed that *A oris* is genetically different from *A naeslundii* and *A viscosus*.^[@bibr4-2324709620910645][@bibr5-2324709620910645]-[@bibr6-2324709620910645]^ However, it is also possible that *A viscosus* or *A naeslundii* in previous reports might be actually *A oris* as the technology at that time might not be able to differentiate these species.

In a literature review, 31 cases of endocarditis caused by *Actinomyces spp* have been reported since 1939 including our case ([Table 2](#table2-2324709620910645){ref-type="table"}). Of the previous case reports of actinomycotic endocarditis, there was only one pediatric case. The median age was 48 years (34-65 years), and 22 patients (71%) were male. Sixteen patients (52%) had underlying cardiac disease. Seven patients (22.6%) had a history of recent dental procedure or presence of dental caries. Twenty-eight cases (90.3%) involved a native valve. Of these 31 cases, 8 patients (25.8%) required cardiac surgery. The overall mortality associated with actinomycotic endocarditis was 25.8% (8 of 31 patients). Clinical characteristics, treatment, and outcome of patients with *Actinomyces* endocarditis are described in [Table 3](#table3-2324709620910645){ref-type="table"}.

###### 

Summary of 30 Reported Cases Diagnosed With Infective Endocarditis Attributable to *Actinomyces* Species.

![](10.1177_2324709620910645-table2)

  Case (Reference)                  Year   Age   Sex      Duration of Illness (Months)   Valve(s)   Predisposing Factors                            Organism                      Therapy                                         Duration of Treatment (Months)   Outcome
  --------------------------------- ------ ----- -------- ------------------------------ ---------- ----------------------------------------------- ----------------------------- ----------------------------------------------- -------------------------------- ----------
  1 ([@bibr17-2324709620910645])    1939   24    Male     1                              MV, AV     None                                            *Actinomyces bovis*           Sulfathiazole                                   NA                               Dead
  2 ([@bibr18-2324709620910645])    1945   55    Male     9                              MV, AV     Aortic insufficiency, dental caries             *Actinomyces graminis*        None                                            NA                               Dead
  3 ([@bibr19-2324709620910645])    1946   39    Male     6 weeks                        MV         Cardiac murmur                                  *Actinomyces septicus*        PCN                                             10                               Survived
  4 ([@bibr20-2324709620910645])    1947   37    Male     NA                             MV         RHD                                             *Actinomyces* spp             Sulfathiazole                                   6                                Dead
  5 ([@bibr20-2324709620910645])    1947   71    Female   NA                             AV         RHD                                             *Actinomyces* spp             None                                            NA                               Dead
  6 ([@bibr21-2324709620910645])    1951   27    Male     2                              MV         RHD                                             *Actinomyces muris*           Chloramphenicol                                 1                                Survived
  7 ([@bibr22-2324709620910645])    1962   43    Male     2                              MV         RHD, dental caries                              *Actinomyces bovis*           PCN                                             5.5                              Survived
  8 ([@bibr23-2324709620910645])    1968   6     Male     NA                             MV         RHD                                             *Actinomyces israelii*        PCN                                             8 days                           Dead
  9 ([@bibr24-2324709620910645])    1976   70    Male     5                              MV         Periodontitis                                   *Actinomyces viscosus*        PCN                                             2.5                              Survived
  10 ([@bibr25-2324709620910645])   1993   65    Male     1                              MV, AV     RHD, H/O endocarditis                           *Actinomyces israelii*        PCN                                             7.5                              Survived
  11 ([@bibr26-2324709620910645])   1996   48    Male     2 weeks                        AV         None                                            *Actinomyces meyeri*          PCN                                             1.5                              Survived
  12 ([@bibr27-2324709620910645])   1997   64    Male     1                              AV         AS                                              *Actinomyces pyogenes*        CTX → VAN + AMP + GEN                           NA                               Dead
  13 ([@bibr15-2324709620910645])   1998   81    Male     2-3 weeks                      AV         Poor dental hygiene                             *Actinomyces viscosus*        Ceftizoxime and CTX                             3                                Survived
  14 ([@bibr28-2324709620910645])   1998   55    Male     NA                             MV         None                                            *Actinomyces meyeri*          AMP/SUL                                         1.5                              Survived
  15 ([@bibr29-2324709620910645])   2001   38    Male     2 weeks                        MV         None                                            *Actinomyces viscosus*        VAN + GEN → CTM + PCN                           NA                               Survived
  16 ([@bibr30-2324709620910645])   2002   40    Female   2 weeks                        TV         Dental root infection, IVDU, H/O endocarditis   *Actinomyces funkei*          Cefuroxime + RIF + CLN → CTX → CLN              NA                               Survived
  17 ([@bibr31-2324709620910645])   2005   33    Male     2                              TV         IVDU, dental procedure                          *Actinomyces odontolyticus*   CTX → PCN + MET                                 NA                               Survived
  18 ([@bibr7-2324709620910645])    2005   43    Female   2 weeks                        AV         Dental cleaning                                 *Actinomyces viscosus*        AMP + azithromycin → VAN + GEN + CTX            1                                Survived
  19 ([@bibr32-2324709620910645])   2007   68    Male     3 weeks                        AV         Dental procedure                                *Actinomyces neuii*           AMP + GEN + CTX → AMP → doxycycline             12                               Survived
  20 ([@bibr33-2324709620910645])   2007   34    Male     NA                             MV         RHD                                             *Actinomyces* spp             NA                                              NA                               Dead
  21 ([@bibr34-2324709620910645])   2008   27    Female   2 days                         EV         IVDU, H/O endocarditis                          *Actinomyces israelii*        Unclear antibiotics, surgery                    NA                               NA
  22 ([@bibr35-2324709620910645])   2008   46    Male     1                              MV         None                                            *Actinomyces georgiae*        PCN → CTX → AMP                                 8.5                              Survived
  23 ([@bibr14-2324709620910645])   2010   66    Male     2                              PAV        Aortic insufficiency                            *Actinomyces neuii*           PCN + MER + ERY → amoxicillin                   12                               Survived
  24 ([@bibr36-2324709620910645])   2010   87    Male     2                              MV         Dental cleaning                                 *Actinomyces israelii*        PCN                                             7.5                              Survived
  25 ([@bibr37-2324709620910645])   2013   49    Male     NA                             TV         IVDU                                            *Actinomyces* spp             Van → CTX → ciprofloxacin + MET                 NA                               Survived
  26 ([@bibr38-2324709620910645])   2014   67    Male     6 weeks                        PAV        Prosthetics, dental cleaning                    *Actinomyces naeslundii*      CTX                                             1.5                              Dead
  27 ([@bibr39-2324709620910645])   2015   30    Female   1 week                         EV         None                                            *Actinomyces turicensis*      PCN → CTX                                       2                                Survived
  28 ([@bibr40-2324709620910645])   2015   51    Female   2                              PAV        Prosthetics, dental caries                      *Actinomyces naeslundii*      VAN + CTX → CTX → ERT → amoxicillin             12                               Survived
  29 ([@bibr41-2324709620910645])   2018   55    Female   8                              MV, AV     HOCM with LVOT                                  *Actinomyces israelii*        PCN                                             11                               Survived
  30 ([@bibr13-2324709620910645])   2019   61    Male     1 week                         MV, AV     H/O MV endocarditis                             *Actinomyces neuii*           VAN + PIP/TAZ → AMP + GEN → AMP → doxycycline   12                               Survived
  This case                         2019   13    Male     2 weeks                        MV, AV     Dental caries, probable RHD                     *Actinomyces oris*            AMP/SUL → AMP → amoxicillin                     12                               Survived

Abbreviations: NA, not applicable; H/O, history of; RHD, rheumatic heart disease; IVDU, intravenous drug use; MV, mitral valve; AV, aortic valve; TV, tricuspid valve; PAV, prosthetic aortic valve; EV, eustachian valve; HOCM, hypertrophic cardiomyopathy; LVOT, left ventricular outlet obstruction; PCN, penicillin; AMP, ampicillin; CTX, ceftriaxone; CTM, cefotaxime; VAN, vancomycin; ERT, ertapenem; MER, meropenem; GEN, gentamicin; AMP/SUL, ampicillin/sulbactam; CLN, clindamycin; ERY, erythromycin; RIF, rifampicin; MET, metronidazole; PIP/TAZ, piperacillin/tazobactam.

###### 

Clinical Characteristics, Treatment, and Outcome of Endocarditis Cases Caused by *Actinomyces* Species.

![](10.1177_2324709620910645-table3)

  Clinical Characteristics                                           N (%)
  ------------------------------------------------------------------ ------------
  Age, years, (range)                                                48 (34-65)
  Sex (male)                                                         22 (71)
  Underlying cardiac disease                                         16 (52)
  History of recent dental procedures or presence of dental caries   7 (22.6)
  Native valve                                                       28 (90.3)
   Mitral valve                                                      11 (35.5)
   Aortic valve                                                      6 (19.4)
   Mitral and aortic valve                                           6 (19.4)
   Eustachian valve                                                  2 (6.5)
  Prosthetic valve                                                   3 (9.7)
  Treatment with non--β-lactams antibiotics                          6 (19.4)
  Required surgery                                                   8 (25.8)
  Duration of treatment (months) (range)                             1-12
  Death                                                              8 (26.7)

Similar to the present case, most of the patients in this review presented with subacute or chronic endocarditis that usually involved native heart valves. Predisposing factors for actinomycotic endocarditis include periodontal diseases or dental procedures in association with a preexisting cardiac valvular defect. Our patient might have had underlying rheumatic heart disease that he had not been aware of. This is a known risk factor for infective endocarditis. Additionally, the pathological findings from the MV and AV were suggestive of post-inflammatory change, which can be seen in rheumatic heart disease. Furthermore, the presence of dental caries, in this case, might be an attributable factor for developing infective endocarditis since *Actinomyces* species habitually colonize in the oral cavity.

The diagnosis of actinomycotic endocarditis primarily depends on the identification of *Actinomyces* species from blood cultures, which may be recognized within 5 to 7 days. However, the cultures should be held for up to 4 weeks to improve the yield of diagnosis. Moreover, blood cultures may fail to identify the organism since these facultative anaerobes require special specimen handling with minimal exposure to oxygen and a need for a CO~2~-enriched environments.^[@bibr7-2324709620910645],[@bibr8-2324709620910645]^ The definitive diagnosis of *Actinomyces* spp has always been challenging. Over the past decade, 16s rRNA sequencing has been widely used for bacterial identification and the discovery of novel bacteria, especially uncultivable or slow-growing bacteria.^[@bibr9-2324709620910645]^ This method has led to the classification and identification of *Actinomyces* spp, differentiating *Actinomyces* spp from other gram-positive anaerobic bacilli.^[@bibr10-2324709620910645]^ However, accurate identification of certain species of actinomycosis is still problematic. MALDI-TOF MS has emerged as a rapid and effective method for bacterial identification with the ability to speciate closely related organisms.^[@bibr11-2324709620910645],[@bibr12-2324709620910645]^ A previous study has demonstrated the performance of MALDI-TOF MS in identification of endocarditis due to *A neuii*.^[@bibr13-2324709620910645]^ As in this case, MALDI-TOF MS was used to confirm the etiologic organism in subacute endocarditis.

The choice and optimal duration of antibiotics in actinomycotic endocarditis remains unclear. *Actinomyces* species are generally susceptible to β-lactam antibiotics. Penicillin or cephalosporins have been considered to be first-line agents for the treatment of actinomycosis. According to previous reports, most patients with endocarditis tended to receive high doses and prolonged antibiotic therapy.^[@bibr14-2324709620910645],[@bibr15-2324709620910645]^ In our literature review, duration of antibiotic therapy ranged from 1 to 12 months. Alternative agents, including chloramphenicol, erythromycin, clindamycin, doxycycline, or vancomycin, have been shown in vitro to be active against these organisms.^[@bibr16-2324709620910645]^ In the present case, the patient was successfully treated with 6 weeks of intravenous ampicillin followed by oral amoxicillin for a planned 12-month course.

In conclusion, we describe a case of native valve *A oris* endocarditis that was successfully treated with intravenous ampicillin and oral amoxicillin and surgical valve replacement. Although infective endocarditis caused by *Actinomyces* spp is rare, it could be considered in a case of culture-negative endocarditis since the clinical features might be indistinguishable from other bacterial endocarditis. Additionally, MALDI-TOF MS could be a useful diagnostic tool for the identification of *Actinomyces* spp to improve the accuracy of speciation and diagnosis.
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